IL227663A - C-4" position substituted macrolide derivative - Google Patents

C-4" position substituted macrolide derivative

Info

Publication number
IL227663A
IL227663A IL227663A IL22766313A IL227663A IL 227663 A IL227663 A IL 227663A IL 227663 A IL227663 A IL 227663A IL 22766313 A IL22766313 A IL 22766313A IL 227663 A IL227663 A IL 227663A
Authority
IL
Israel
Prior art keywords
group
formula
substituted
compound
represented
Prior art date
Application number
IL227663A
Other languages
English (en)
Hebrew (he)
Other versions
IL227663A0 (en
Original Assignee
Taisho Pharmaceutical Co Ltd
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46721028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL227663(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of IL227663A0 publication Critical patent/IL227663A0/en
Publication of IL227663A publication Critical patent/IL227663A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL227663A 2011-02-21 2013-07-25 C-4" position substituted macrolide derivative IL227663A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011034578 2011-02-21
PCT/JP2012/054677 WO2012115256A1 (en) 2011-02-21 2012-02-20 C-4" position substituted macrolide derivative

Publications (2)

Publication Number Publication Date
IL227663A0 IL227663A0 (en) 2013-09-30
IL227663A true IL227663A (en) 2017-09-28

Family

ID=46721028

Family Applications (1)

Application Number Title Priority Date Filing Date
IL227663A IL227663A (en) 2011-02-21 2013-07-25 C-4" position substituted macrolide derivative

Country Status (35)

Country Link
US (1) US9139609B2 (enExample)
EP (1) EP2678349B1 (enExample)
JP (1) JP5687777B2 (enExample)
KR (1) KR20140008388A (enExample)
CN (1) CN103492404B (enExample)
AR (1) AR085286A1 (enExample)
AU (1) AU2012222267B2 (enExample)
BR (1) BR112013020118A2 (enExample)
CA (1) CA2827474A1 (enExample)
CL (1) CL2013002313A1 (enExample)
CO (1) CO6801737A2 (enExample)
CY (1) CY1117381T1 (enExample)
DK (1) DK2678349T3 (enExample)
ES (1) ES2566368T3 (enExample)
HR (1) HRP20160252T1 (enExample)
HU (1) HUE028245T2 (enExample)
IL (1) IL227663A (enExample)
IN (1) IN2013CN07459A (enExample)
ME (1) ME02475B (enExample)
MX (1) MX2013009585A (enExample)
MY (1) MY161451A (enExample)
NZ (1) NZ613956A (enExample)
PE (1) PE20140649A1 (enExample)
PH (1) PH12013501695B1 (enExample)
PL (1) PL2678349T3 (enExample)
RS (1) RS54635B1 (enExample)
RU (1) RU2599718C2 (enExample)
SA (1) SA112330287B1 (enExample)
SG (1) SG192655A1 (enExample)
SI (1) SI2678349T1 (enExample)
SM (1) SMT201600106B (enExample)
TW (1) TWI513704B (enExample)
UA (1) UA111191C2 (enExample)
WO (1) WO2012115256A1 (enExample)
ZA (1) ZA201305983B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
CN105085590A (zh) * 2014-05-16 2015-11-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) * 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 C-4"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN108610388B (zh) * 2016-12-12 2020-11-06 浙江京新药业股份有限公司 一种大环内酯的制备方法
CN109425666B (zh) * 2017-08-28 2022-07-08 广东东阳光药业有限公司 一种酰氯衍生物的lc-ms分析方法
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
TW202535873A (zh) 2019-09-26 2025-09-16 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物
CN111423482B (zh) * 2020-04-26 2023-01-17 梯尔希(南京)药物研发有限公司 一种同位素标记的红霉胺的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US5393743A (en) 1993-07-06 1995-02-28 Abbott Laboratories Erythromycin derivatives
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
RU2144541C1 (ru) * 1995-12-08 2000-01-20 Руссель Юклаф Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция
ES2242983T3 (es) 1996-09-04 2005-11-16 Abbott Laboratories Cetolidos 6-0-sustituidos que tienen una actividad antibacteriana.
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
BR0010938A (pt) * 1999-05-24 2002-03-19 Pfizer Prod Inc Derivados da 13-metil eritromicina
UY26964A1 (es) 2000-10-16 2002-06-20 Abbott Lab Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
US20080203485A1 (en) 2007-02-28 2008-08-28 International Business Machines Corporation Strained metal gate structure for cmos devices with improved channel mobility and methods of forming the same
WO2008143729A2 (en) * 2007-02-28 2008-11-27 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same

Also Published As

Publication number Publication date
RS54635B1 (sr) 2016-08-31
SA112330287B1 (ar) 2015-10-11
IN2013CN07459A (enExample) 2015-04-24
SI2678349T1 (sl) 2016-04-29
EP2678349B1 (en) 2016-01-13
TW201247693A (en) 2012-12-01
HRP20160252T1 (hr) 2016-04-22
EP2678349A1 (en) 2014-01-01
PH12013501695B1 (en) 2018-07-11
CY1117381T1 (el) 2017-04-26
US9139609B2 (en) 2015-09-22
JP5687777B2 (ja) 2015-03-18
CN103492404A (zh) 2014-01-01
BR112013020118A2 (pt) 2017-07-18
MX2013009585A (es) 2014-06-05
DK2678349T3 (en) 2016-03-07
HUE028245T2 (en) 2016-12-28
TWI513704B (zh) 2015-12-21
CA2827474A1 (en) 2012-08-30
US20140046043A1 (en) 2014-02-13
WO2012115256A1 (en) 2012-08-30
RU2599718C2 (ru) 2016-10-10
CN103492404B (zh) 2016-09-07
AU2012222267A1 (en) 2013-08-22
JP2014505723A (ja) 2014-03-06
PL2678349T3 (pl) 2016-06-30
SMT201600106B (it) 2016-04-29
AU2012222267B2 (en) 2016-07-07
CO6801737A2 (es) 2013-11-29
ZA201305983B (en) 2014-11-26
ES2566368T3 (es) 2016-04-12
IL227663A0 (en) 2013-09-30
EP2678349A4 (en) 2014-07-30
CL2013002313A1 (es) 2014-08-08
RU2013142898A (ru) 2015-03-27
KR20140008388A (ko) 2014-01-21
AR085286A1 (es) 2013-09-18
SG192655A1 (en) 2013-09-30
ME02475B (me) 2017-02-20
PH12013501695A1 (en) 2013-10-07
NZ613956A (en) 2014-07-25
UA111191C2 (uk) 2016-04-11
MY161451A (en) 2017-04-14
PE20140649A1 (es) 2014-06-25

Similar Documents

Publication Publication Date Title
IL227663A (en) C-4" position substituted macrolide derivative
US8097708B2 (en) 10a-Azalide compound
RU2455308C2 (ru) Макролидные производные
JP5857008B2 (ja) C−4”位置換マクロライド誘導体を含有する医薬
JP2005526050A (ja) 抗菌活性を有するマクロライド
US8299035B2 (en) 10a-azalide compound having 4-membered ring structure
AU2025205323A1 (en) Fused heterocycles as 5-ht2a receptor agonists
WO2013004116A1 (zh) C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
JP2014058507A (ja) 11位アミノ置換マクロライド誘導体
HK1191338A (en) C-4"position substituted macrolide derivative
HK1191338B (en) C-4"position substituted macrolide derivative
US20040127433A1 (en) Erythromycin derivative and medicament comprising the same
JP2000351793A (ja) エリスロマイシン誘導体
JP2014058508A (ja) 9位オキシム置換マクロライド誘導体
HK1133037B (en) Macrolide derivative
HK1184162A (en) Macrolide derivatives

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees